Covered recipient · General Payments record
SUSAN ELLIOTT
Allopathic & Osteopathic Physicians Anesthesiology
General Payments · PY2022–2024
$2,056.71
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $453.57 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $238.10 | 5 |
| Collegium Pharmaceutical, Inc. | $46.94 | 2 |
| Azurity Pharmaceuticals, Inc. | $37.28 | 2 |
| SI-BONE, INC. | $35.10 | 1 |
| Nevro Corp. | $29.18 | 2 |
| SPR Therapeutics, Inc | $27.09 | 1 |
| Virtus Pharmaceuticals LLC | $24.48 | 1 |
| FORTE BIO-PHARMA LLC | $15.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Azurity Pharmaceuticals, Inc. | $19.48 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134017071 | CMS |
| Azurity Pharmaceuticals, Inc. | $17.80 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134017073 | CMS |
| Collegium Pharmaceutical, Inc. | $24.02 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135265617 | CMS |
| Collegium Pharmaceutical, Inc. | $22.92 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135317242 | CMS |
| Forte Bio-Pharma LLC | $15.40 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142422855 | CMS |
| Medtronic, Inc. | $16.92 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116890651 | CMS |
| Medtronic, Inc. | $26.29 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116890653 | CMS |
| Medtronic, Inc. | $117.03 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116890657 | CMS |
| Medtronic, Inc. | $49.41 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116890659 | CMS |
| Medtronic, Inc. | $28.45 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116890655 | CMS |
| Nevro Corp. | $14.93 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130766407 | CMS |
| Nevro Corp. | $14.25 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130766409 | CMS |
| SI-BONE, INC. | $35.10 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120066113 | CMS |
| SPR Therapeutics, Inc | $27.09 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104945686 | CMS |
| Virtus Pharmaceuticals LLC | $24.48 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112837116 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.